Financials
- Market Capitalization 1.82 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.74
売上高対価格比率
941.13
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2070 | SEPN Septerna, Inc. - Common Stock | 38.92 USD | -3.83% | -4.40% | +14.57% | +76.83% | 1.82 B USD | ||
| 2075 | FTRE Fortrea Holdings Inc. - Common Stock | 18.85 USD | -0.05% | +2.50% | -3.78% | +93.14% | 1.79 B USD | ||
| 2082 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +0.23% | +19.50% | -6.20% | 1.80 B USD | ||
| 2085 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -3.20% | -4.86% | +9.90% | -31.34% | 1.78 B USD |